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A quarter of a century has passed since bombyxin, the first insulin-like peptide identified in
insects, was discovered in the silkmoth Bombyx mori. During these years, bombyxin has
been studied for its structure, genes, distribution, hemolymph titers, secretion control, as
well as physiological functions, thereby stimulating a wide range of studies on insulin-like
peptides in other insects. Moreover, recent studies have identified a new class of insulin
family peptides, IGF-like peptides, in B. mori and Drosophila melanogaster, broadening
the base of the research area of the insulin-related peptides in insects. In this review, we
describe the achievements of the studies on insulin-like and IGF-like peptides mainly in
B. mori with short histories of their discovery. Our emphasis is that bombyxins, secreted
by the brain neurosecretory cells, regulate nutrient-dependent growth and metabolism,
whereas the IGF-like peptides, secreted by the fat body and other peripheral tissues,
regulate stage-dependent growth of tissues.
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INTRODUCTION
THE AIM OF THIS REVIEW
Since 1984, when bombyxin was identified as the first insulin-
like peptide in invertebrates (Nagasawa et al., 1984b), this brain
neurosecretory hormone of the silkmoth Bombyx mori has been
extensively characterized for its chemical nature, gene structure,
distribution, secretion control, as well as physiological functions.
In addition, another class of insulin-related peptides has recently
been discovered again in B. mori and characterized (Okamoto
et al., 2009a). The former is similar to vertebrate insulin in its
two-chain structure and physiological functions, while the latter
to vertebrate insulin-like growth factors (IGFs) in its single-chain
structure, sites of production and physiological roles. In this
article, we will provide an overview of the accumulated knowl-
edge on these two classes of Bombyx insulin-related peptides and
discuss the physiological significance of the presence of these hor-
mones in insects. Recently, physiological functions and action
mechanisms of insect insulin/IGF-like peptides have been actively
studied in other insects, especially in the fruit fly Drosophila
melanogaster, by using genetic approaches. In this review, how-
ever, we will concentrate on the achievements with B. mori,
because comprehensive reviews exist for Drosophila and other
insects (Garofalo, 2002; Oldham and Hafen, 2003; Tatar et al.,
2003; Géminard et al., 2006; Wu and Brown, 2006; Broughton
and Partridge, 2009; Grewal, 2009; Teleman, 2010; Grönke and
Partridge, 2010; Antonova et al., 2012; Nässel, 2012; Hyun, 2013).
HISTORICAL BACKGROUND
Insulin is best known for its hypoglycemic action (Newsholme
et al., 1992; Saltiel and Kahn, 2001). Even before the discov-
ery of bombyxin, the existence of hypoglycemic hormones had
been demonstrated in the honeybee Apis mellifera (Kramer et al.,
1977, 1982; Bounias et al., 1986), the blowfly Calliphora vomitoria
(Duve et al., 1979), the tobacco hornworm Manduca sexta (Tager
et al., 1976; Kramer et al., 1982), the cockroach Periplaneta amer-
icana (Barrett and Loughton, 1987) and others (for a review, see
Kramer, 1985). These hypoglycemic hormones were presumed to
be insulin-related peptides, because insulin-immunoreactive sub-
stances had also been detected in many insects including above-
mentioned species as well as the locust Locusta migratoria and the
silkmoth B. mori by radioimmunoassay (RIA) (Ishay et al., 1976;
Tager et al., 1976; Kramer et al., 1977; Duve et al., 1979; Orchard
and Loughton, 1980; Kramer, 1985) and/or immunocytochem-
istry (Duve and Thorpe, 1979; Yui et al., 1980). These insulin-like
peptides in most insects were localized in the neurosecretory
cells of the brain and its neurohemal organs, corpora cardiaca
(CC) and/or corpora allata (CA), and were therefore recognized
as brain neurosecretory hormones. The insulin-immunoreactive
material was purified and chemically characterized in M. sexta
(Kramer et al., 1982) and C. vomitoria (Thorpe and Duve, 1984).
Although the amino acid sequence was not determined, their
molecular size and amino acid composition were similar to those
of vertebrate insulins.
BOMBYX INSULIN-LIKE PEPTIDE (BOMBYXIN)
DISCOVERY OF BOMBYXIN
Bombyxin was initially called 4K-prothoracicotropic hormone
(4K-PTTH), because it was purified as the brain neurosecre-
tory hormone with MW of 4400 that stimulates the prothoracic
glands (PGs) to release ecdysone (Nagasawa et al., 1984b, 1986).
In this purification study, the adult heads of B. mori were used
as the starting material for purification and the debrained dor-
mant pupae of the heterologous moth Samia cynthia ricini were
used for the bioassay of the hormone, because PTTHwas believed
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to be species-nonspecific between these two species and because
Samia debrained pupae provided a more stable assay system than
Bombyx debrained pupae (see Ishizaki, 2004 for more detailed
history of bombyxin and PTTH purifications). In fact, crude
extracts of B. mori brain were able to provoke adult development
when injected into debrained dormant pupae of both B. mori and
S. cynthia ricini. At the final stage of purification, however, the
purified 4K-PTTH was found to be ineffective on the PGs of B.
mori from which it was derived (Ishizaki et al., 1983), indicating
that this peptide is not the true PTTH of B. mori. Nevertheless,
the name 4K-PTTH was used for years thereafter, because it was
actually highly active on the Samia PGs both in vivo and in vitro
(Nagasawa et al., 1984a). This peptide was purified to homogene-
ity and its partial sequence determined in 1984 (Nagasawa et al.,
1984a,b). Surprisingly, the N-terminal sequence of 4K-PTTHwas
structurally homologous to vertebrate insulin and IGF (see sec-
tion Primary Structure). This was the first insulin-related peptide
identified in invertebrates. Thus, this peptide was finally renamed
bombyxin for Bombyx insulin (Mizoguchi et al., 1987).
PRIMARY STRUCTURE
4K-PTTH was purified to homogeneity through 15 steps of
purification from 678,000 Bombyx adult heads, yielding three
peaks on HPLC. Each peak contained 36–50μg of peptide,
and was sequenced separately. The N-terminal 19 amino acid
sequences of these peptides, named 4K-PTTH-I, II, III, were sim-
ilar to each other and even to the corresponding portions of
human insulin and IGF-I (Nagasawa et al., 1984b). The com-
plete amino acid sequence was determined later for 4K-PTTH-II
(Nagasawa et al., 1986; for minor revision, see Nagasawa et al.,
1988). It consisted of two non-identical peptide chains (A and B
chains), like vertebrate insulin. The A and B chains consisted of
20 and 28 amino acid residues, respectively. 4K-PTTH-II showed
high sequence identity (∼40%) with human insulin, and the posi-
tions of seven cysteine residues were completely identical with
those in other insulin family peptides.
HIGHER STRUCTURE
The location of disulfide bridges in the molecule was deter-
mined through thermolysin digestion of 4K-PTTH-II (hereafter
bombyxin-II) and subsequent chemical analyses (Nagasawa et al.,
1988). Three disulfide bonds were linked in the same positions as
in insulin.
A three-dimensional model of bombyxin-II was constructed
using interactive computer graphics and energy minimization
techniques (Jhoti et al., 1987), confirming the insulin-like struc-
ture of bombyxin-II (called PTTH-II in the paper). This model
predicts that bombyxin-II is unlikely to form either dimers or
hexamers, characteristic of human insulin and that a hydropho-
bic surface region of the peptide may be important in binding
with other proteins.
In addition to bombyxin-I, -II, -III, two more bombyxin
species have been isolated from Bombyx heads. The primary
structure of bombyxin-IV was determined for both chains
(Maruyama et al., 1988), and that of bombyxin-V for the B-chain
(Jhoti et al., 1987). Bombyxin-IV had 62.5% sequence identity
with bombyxin-II.
Bombyxin-II and -IV were chemically synthesized by solid
phase peptide synthesis of the A- and B-chains followed by air
oxidation (Nagasawa et al., 1988) or semicontrolled pairing of
cysteine residues (Maruyama et al., 1990) in a yield of 4 and 8%,
respectively. The synthetic bombyxin-II and -IV had nearly the
same specific activity as the natural ones.
By using the synthetic bombyxin-II, its three-dimensional
solution structure was determined by NMR measurements
(Nagata et al., 1995a). Although the overall main-chain structure
of bombyxin-II was similar to that of insulin, significant confor-
mational and functional differences in their B-chain C-terminal
portions were found. This part of bombyxin-II adopts an exten-
sion of the B-chain central helix like that of relaxin and is not
required for bombyxin activity, contrasting with the correspond-
ing part of insulin, which adopts a sharp turn and a β-strand
and is essential for insulin activity. A further study employing
chimeric molecules of bombyxin-II and human insulin sug-
gested that the surface patch formed by the central part of the
bombyxin-II B-chain is of critical importance for recognition of
the bombyxin receptor (Nagata et al., 1995b).
BOMBYXIN GENES
Although the above purification study revealed an abundance of
molecular forms of bombyxin, the subsequent molecular cloning
studies have identified more genes encoding bombyxins. Thirty-
two bombyxin-encoding genes have been cloned (Iwami et al.,
1989, 1990; Kawakami et al., 1989; Kondo et al., 1996; Tsuzuki
et al., 1997; Yoshida et al., 1997, 1998). In addition, some more
bombyxin genes have been identified by the BLAST searches
on the Bombyx genome (Aslam et al., 2011). The cloned genes
are classified into 7 families, A–G, according to their sequence
similarity. The families A, B, and C consist of 10, 12, and 6
genes, respectively, and each of the families D–G contains a sin-
gle gene (Iwami, 2000). Among these genes, A6 and/or A7 encode
bombyxin-II, and E1 encode bombyxin-IV. However, the genes
coding for bombyxin-I, III, and V have not been identified. Most
bombyxin genes encode polypeptides similar to preproinsulin,
which consists of the signal peptide, B-chain, C-peptide, and A-
chain, in this order, from the N-terminus, although several other
genes are presumably pseudogenes (Kondo et al., 1996). Novel
bombyxin genes recently identified in the Bombyx genome are
classified into five different families, V–Z (Aslam et al., 2011).
Each family contains a single gene except for family V, which
includes two closely related genes. These new bombyxin genes
also code for preproinsulin-like structure, similar to the fam-
ily A–G genes. The similarities in the amino acid sequences
of preprobombyxins between families are about 50% (Iwami,
2000). The sequence similarities are high in the A- and B-chains
(domains) but low in the C-peptide (domain).
All six cysteines and some hydrophobic residues in the A- and
B-domains responsible for the formation of a hydrophobic core
are completely conserved in all probombyxins and insulin. The
C-domains of all probombyxins are flanked by dibasic (monoba-
sic in some cases) sites, suggesting that the C-domain is removed
to generate mature bombyxins in the same way as insulin matu-
ration. However, this may be the case only when the bombyxin
genes are expressed in specific tissues such as the brain, from
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which bombyxin-II and -IV were purified. These two bombyxins
have been confirmed to consist of A- and B-chains like insulin,
as described above. In 2009, however, a novel insulin family pep-
tide containing the C-domain was purified from Bombyx pupal
hemolymph [(Okamoto et al., 2009a); see section Bombyx IGF-
Like Peptide (BIGFLP) for details]. This peptide, named Bombyx
IGF-like peptide (BIGFLP), is the product of the bombyxin Y1
gene (Aslam et al., 2011), and its C-domain is also flanked by
dibasic sites. However, this peptide is secreted with the C-domain
intact. Its main production site is the fat body. It is probable that
fat body cells lack the enzyme(s) that cleaves peptides at dibasic
sites. The discovery of BIGFLP suggests that the mature form of
bombyxin depends on the type of cells where the bombyxin gene
is expressed.
A remarkable feature of most bombyxin genes is a lack of any
introns (Iwami, 2000), since vertebrate insulins consistently have
two introns at conserved sites, one in the 5′-UTR and the other in
the C-domain (Steiner et al., 1985). However, three of the recently
identified bombyxin genes were found to have introns. Bombyxin-
V1 and -V2 each had one intervening intron of different length
in the 5′-UTR, and bombyxin-Z1 contained two introns in the
5′ UTR and one intron within the C-domain (Aslam et al., 2011).
In the Bombyx genome, most bombyxin genes are clustered in
two segments on chromosome 11 (25 genes) and an unidentified
chromosome (6 genes), while forming gene pairs, gene triplets,
or single genes. Other genes are located singly on chromosome 1
(3 genes), chromosome 9 (2 genes), and chromosome 11 (1 gene)
(Iwami, 2000; Aslam et al., 2011).
BOMBYXIN BIOSYNTHESIS AND RELEASE
BOMBYXIN-PRODUCING CELLS
Bombyxin-producing cells were first identified by immunocyto-
chemistry using a mouse monoclonal antibody (AN-I) generated
against a synthetic decapeptide corresponding to the N-terminal
portion of the A-chain of bombyxin-I (Mizoguchi et al., 1987).
This antibody immunostained four pairs of large mid-dorsal neu-
rosecretory cells of the brain and thick and dense nerve fibers
around the periphery of the CA, suggesting that bombyxin is
produced by these neurosecretory cells, axonally transported to
and released from the CA. The axonal pathway of the bombyxin-
containing neurons was not clear in this study, because immuno-
histochemistry was performed on brain sections. However, the
subsequent study employing intracellular injection of Lucifer yel-
low (Ichikawa, 1991) or whole-mount immunohistochemistry
(Figure 1) confirmed the connection between the medial neu-
rosecretory cells (MNCs) in the brain and the axon terminals in
the CA. These studies revealed that the axons originating from the
four MNCs are fasciculated, traverse the midline of the brain to
enter the contralateral lobe, and proceed along the ventral surface
of the brain toward the retrocerebral nerve. The axons descend
down the nerve, pass through the CC, and terminate in the CA
with branches. Lucifer yellow injection in bombyxin-producing
cells also revealed thick ipsilateral and thin contralateral dendrites
as well as an abundance of varicosities along the branched axons
over the periphery of the CA (Ichikawa, 1991).
Developmentally, the number of bombyxin-producing neu-
rosecretory cells in the brain is consistently four throughout
FIGURE 1 | Bombyxin-producing neurosecretory cells. Whole-mount
immunohistochemistry with anti-bombyxin-II mouse monoclonal antibody
(A7B11) was performed on the brain-retrocerebral complex of the day-3 fifth
instar larva of B. mori. BR, brain; CA, corpus allatum.
postembryonic development from hatching through adult eclo-
sion (Mizoguchi et al., 1990). However, the immunoreactivity
of the cells has been shown to markedly change during Bombyx
development, especially in the fifth instar. For the first three days
of the instar, the four pairs of cells are heavily stained but there-
after the stainability is impaired. Interestingly, two of these cells
in each brain hemisphere are relatively intensely stained whereas
the other two cells stained poorly. This unequal stainability of
the cells might represent a pulsatile secretion of bombyxin. The
immunoreactivity becomes weakest on the day of wandering and
is then gradually regained (Mizoguchi et al., 1990).
The bombyxin-producing cells in the brain have also been
identified by in situ hybridization. The bombyxin genes of fam-
ilies A–F, V, W, and Y are all expressed in four pairs of MNCs of
the fifth larval brain (Iwami, 2000; Aslam et al., 2011), indicating
that these cells are the exclusive source of bombyxin in the brain.
Early investigations by Northern hybridization could not
detect bombyxin expression in tissues other than brain (Adachi
et al., 1989; Iwami et al., 1990). However, RT-PCR analyses have
disclosed that bombyxin genes are ubiquitously expressed in lar-
val tissues, although the level of expression is very low if compared
to that in the brain (Iwami et al., 1996). Moreover, it has recently
been shown that some “bombyxin” genes are expressed predom-
inantly in the fat body and/or gonads in a stage specific manner.
Such genes include bombxin-X1, Y1 and ZI genes (Aslam et al.,
2011). However, calling them “bombyxin” genes is controversial,
because one of the products of these genes has been shown to
be more like IGF rather than insulin in its structural features
and physiological roles [see section Bombyx IGF-Like Peptide
(BIGFLP)]. If bombyxin is defined as a structurally and function-
ally insulin-like peptide of B. mori, the IGF-like peptide should
be called by other name. In this review, we discriminate the
insulin-related peptides produced mainly by peripheral tissues
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from bombyxins, which are produced predominantly by the brain
neurosecretory cells.
MEASUREMENT OF BOMBYXIN
Bombyxin titers in the hemolymph have been determined by
RIA (Saegusa et al., 1992; Masumura et al., 2000) or time-
resolved fluoroimmunoassay (TR-FIA) (Satake et al., 1997). RIA
was developed using a mouse monoclonal antibody (M7H2) gen-
erated against pure native bombyxin-II and 125I-labeled native
bombyxin-II. The bombyxin concentration determined by this
RIA was expressed by Samia units/ml, because a partially puri-
fied bombyxin was used as the standard, due to a paucity of the
pure hormone. The lower limit of detection was equivalent to 0.2
Samia units (as determined by the Samia pupal assay) of bom-
byxin contained in the partially purified bombyxin. One Samia
unit corresponds to 0.1 ng of bombyxin-I and -III and 0.4 ng of
bombyxin-II (Nagasawa et al., 1984b). Therefore, the sensitiv-
ity of this RIA can be roughly estimated to be several tens of
picograms, assuming that the anti-bombyxin-II antibody binds to
any bombyxin species with the same affinity. In fact, however, the
cross-reactivity of this antibody to other bombyxin species is not
known. Nevertheless, this RIA provided a valuable opportunity
to assess the physiological function of bombyxin and to analyze
the regulation of its secretion. The titers of bombyxin immunore-
activity in the hemolymph were relatively constant during larval
development with no correlation with ecdysteroid peaks, con-
firming that this hormone is not involved in the regulation of
PG activity (Saegusa et al., 1992). Although the hemolymph titers
of bombyxin immunoreactivity determined by RIA were remark-
ably high during pupa-adult development, this immunoreactivity
in the pupal hemolymph was later proved not to represent bom-
byxin but to denote other bombyxin-related peptide. However,
without this information about very high bombyxin titers in
the pupal hemolymph, the recent discovery of an IGF-like pep-
tide may not have been achieved [see section Bombyx IGF-Like
Peptide (BIGFLP)]. The same RIA was applied to investigate the
effects of starvation and feeding of larvae on bombyxin secretion
(Masumura et al., 2000), revealing an important aspect of bom-
byxin secretion (see section Regulation of Bombyxin Release).
More recently, a TR-FIA based on a sandwich protocol has
been developed using two kinds of monoclonal antibodies against
synthetic bombyxin-II (A3A1 and A7B11), one of which was
biotin-labeled and used as a tracer antibody, and the other used as
a capture antibody (Satake et al., 1997). The lower limit of detec-
tion by this assaywas 3 pg (bombyxin-II equivalents), much lower
than that of the RIA. This TR-FIA was applied to measure bom-
byxin titers in the hemolymph of Bombyx adults, revealing that
bombyxin is released immediately after eclosion in a sex-specific
manner (Satake et al., 1999). The peak bombyxin titer was three
times higher in males. However, the physiological relevance of the
bombyxin release at this stage and its sex difference remains to be
elucidated.
REGULATION OF BOMBYXIN RELEASE
The effects of starvation and refeeding on bombyxin secretion
were investigated in Bombyx larvae. The release of bombyxin was
monitored by measuring hemolymph titers and brain contents of
bombyxin by RIA (Masumura et al., 2000). Following starvation
for 3–6 h, the hemolymph titer decreased, while the brain content
increased significantly. By contrast, refeeding after 6 h-starvation
resulted in a quick recovery of the hemolymph bombyxin titer
as well as a quick decrease in the brain bombyxin content. These
results clearly demonstrated that bombyxin release is closely asso-
ciated with feeding. In humans, insulin secretion is stimulated
by hyperglycemia after a meal. The glucose levels in Bombyx
hemolymph also change dramatically after starvation and refeed-
ing. Therefore, the effect of glucose on bombyxin release was
examined by injecting D-glucose into starved larvae. The brain
bombyxin content decreased within 1 h after glucose injection in a
dose-dependent manner. This result indicates that glucose serves
as a common nutritional signal for inducing the release of both
mammalian and insect insulins as a messenger for the “fed” state
of the body.
It is unclear whether the bombyxin-producing cells directly
respond to circulating glucose or not. In D. melanogaster, the
secretion of insulin-like peptides (DILPs) from the brain also
depends on the nutritional conditions, but the availability of
nutrients is remotely sensed by the fat body, which in turn reg-
ulates DILP secretion through humoral factors (Géminard et al.,
2009; Bai et al., 2012; Rajan and Perrimon, 2012). In this case, the
major nutritional signal in the diet is not glucose but amino acids
(Géminard et al., 2009).
BOMBYXIN ACTIONS
REGULATION OF TREHALOSE METABOLISM
When bombyxin was purified from B. mori, no physiological
action of this peptide was known in B. mori from which it
was derived (see section Discovery of Bombyxin). Prior to the
identification of bombyxin as an insulin-related peptide, how-
ever, the presence in several insects of insulin-like hypoglycemic
hormones had been repeatedly suggested (see section Historical
Background). Thus, soon after a synthetic bombyxin-II was
obtained (Nagata et al., 1992), the effects of bombyxin on
sugar metabolism were investigated. Bombyxin-II lowered the
concentration of the major hemolymph sugar, trehalose, in a
dose-dependent manner when injected into neck-ligated Bombyx
larvae (Satake et al., 1997).
Bombyxin-II injection also led to the elevation of trehalase
activity in the midgut and muscle (Satake et al., 1997). Trehalase
located on the cell surface is assumed to hydrolyze trehalose in the
hemolymph to glucose for transport into the cells (Shimada and
Yamashita, 1979; Azuma and Yamashita, 1985). Therefore, these
observations suggest that bombyxin induces hypotrehalosemia by
promoting the hydrolysis of hemolymph trehalose to glucose and
thereby facilitating its incorporation into tissues. However, such
effects of bombyxin on trehalose metabolism may be larval stage-
specific, because bombyxin-II injection into adults did not result
in hypotrehalosemia (Satake et al., 1999).
Glucose also constitutes the hemolymph sugar in B. mori,
although its concentration is very low as compared with that of
trehalose. Interestingly, bombyxin-II injection did not affect the
glucose concentration in the hemolymph (Satake et al., 1997).
REGULATION OF GLYCOGENMETABOLISM
In mammals, insulin not only promotes glucose uptake by adi-
pose tissue and muscle but also facilitates glycogen production in
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some tissues including liver and muscle (Newsholme et al., 1992;
Saltiel and Kahn, 2001). Therefore, the effect of bombyxin on tis-
sue glycogen content was also examined. Unexpectedly, glycogen
content in the fat body, amajor glycogen storage tissue, was signif-
icantly decreased, but not increased, after bombyxin-II injection
(Satake et al., 1997).
The effect of bombyxin on the activity of glycogen phos-
phorylase, a key enzyme of glycogenolysis, was also examined.
When 10 ng of bombyxin-II was injected, the percentage of active
glycogen phosphorylase was significantly increased, providing a
biochemical basis for the glycogen-reducing effect of bombyxin
(Satake et al., 1997).
It is worth noting that hemolymph trehalose and fat body
glycogen are both major storage forms of carbohydrates in insect.
Thus, the results of these investigations suggest that bombyxin
likely functions to facilitate the use of energy reserves.
REGULATION OF TISSUE GROWTH
The growth-promoting action of bombyxin on wing imagi-
nal discs has been demonstrated in the butterfly Precis coenia
(Nijhout and Grunert, 2002). Although the wing disc of the final
instar larva does not grow in vitro in the standard tissue culture
medium without supplements, it does grow in the medium sup-
plemented with an optimal concentration of 20-hydroxyecdysone
(20E, 0.1 ng/ml) andwith hemolymph taken from growing larvae.
Assuming that the factor in the hemolymph responsible for the
promoted growth of the disc is bombyxin, the effect of bombyxin-
II on the disc growth in vitro was examined, using mitotic rate
as an indicator of its growth. Bombyxin-II elevated the mitotic
rate in a dose-dependent manner when added together with
0.1mg/ml 20E to the culture. Moreover, the growth-promoting
effect of the hemolymph was abolished when the hemolymph
was pretreated with bombyxin antibodies (AN-I and guinea pig
polyclonal antibody against synthetic bombyxin-II)-bound col-
umn to remove bombyxin, leading the authors to conclude that
bombyxin is a growth factor for wing imaginal discs (Nijhout
and Grunert, 2002). A similar effect of bombyxin-II on wing disc
growth has also been reported in M. sexta (Nijhout et al., 2007).
Bombyxin-II also promotes cell proliferation in the
hematopoietic organ (HPO) of B. mori. Cell proliferation
in the larval HPOs cultured in vitro is markedly promoted
by B. mori larval hemolymph. Thus, the active factor in the
hemolymph has again been presumed to be bombyxin. When the
HPOs from day-1 fifth instar larvae were cultured for 48 h with
bombyxin-II, the number of discharged hemocytes increased in
a dose-dependent manner (Nakahara et al., 2006). Because the
hemocyte discharge is linked to cell proliferation (Nakahara et al.,
2003), this result shows mitogenic activity for bombyxin-II. In
contrast to the above study with the Precis wing discs, bombyxin-
II was still effective in the absence of 20E. 20E was also mitogenic
to the HPO irrespective of the presence of bombyxin-II. Despite
the clear action of bombyxin-II on the HPO, the authors con-
cluded that bombyxin is not the primary effector in the larval
hemolymph, because anti-bombyxin-II antibodies (a mixture of
M7H2, A3A1, A7B11, and guinea pig polyclonal antibody) were
unable to neutralize the mitogenic activity of the hemolymph.
However, this conclusionmight be premature, because bombyxin
is highly heterogeneous and the anti-bombyxin-II antibodies are
only able to recognize a part of many bombyxin molecular species
(Saegusa et al., 1992).
The effect of bombyxin on the systemic growth of lepidopteran
insects including B. mori has not been investigated due to the
difficulties in applying genetic approaches to analyze bombyxin
actions in this order of insects (Terenius et al., 2011). However,
such an effect of bombyxin homologues has been extensively
studied in D. melanogaster, which has eight insulin-like peptides
(DILP1-8) (Brogiolo et al., 2001; Colombani et al., 2012; Garelli
et al., 2012). Among them, dilp2, −3, and−5 aremainly expressed
in the MNCs of the brain as with bombyxin (Brogiolo et al., 2001;
Ikeya et al., 2002; Rulifson et al., 2002; Broughton et al., 2005;
Nässel, 2012) and their products are thus thought to be functional
homologues of bombyxins. When individual dilps (dilp1-7) were
overexpressed, a proportionate increase in body size was observed
in adult flies (Brogiolo et al., 2001; Ikeya et al., 2002), with dilp2
showing the highest potency for growth promotion (Ikeya et al.,
2002). The dilp2-overexpressed flies exhibited larger wing size due
to increases in both cell size and cell number. In contrast, when
the DILP-producing MNCs in the brain were genetically ablated
using a dilp2 promoter to express the apoptotic gene, reaper, larval
growth was severely retarded, puparium formation delayed, and
adult size reduced. All these phenotypes were rescued by ubiqui-
tously expressing dilp2 using heat-shock promoter (Rulifson et al.,
2002). These results clearly demonstrate that the DILPs secreted
from the MNCs are potent regulators of the systemic growth of
Drosophila.
OTHER KNOWN ACTIONS
A highly purified preparation of bombyxin induced meiosis in
the ovaries that were taken from young Bombyx larvae and
cultured in vitro (Orikasa et al., 1993). However, the authors
proposed that bombyxin merely stimulates the ovaries to pro-
duce ecdysteroids, which in turn induce meiosis of the ovarian
cells, because 20E also induces meiosis at a very low concen-
tration (Orikasa et al., 1993) and because the ovaries from
the fourth instar Bombyx larvae secrete ecdysteroids in vitro
(Orikasa, unpublished).
It has also been reported that synthetic bombyxin-II induces a
series of morphological changes in BM-N4 cells (Tanaka et al.,
1995), a cell line established from ovarian tissues of B. mori
(Volkman andGoldsmith, 1982). After bombyxin administration,
most of the cells became bigger and round in shape and aggre-
gated to form clumps. Some other cells were tightly attached to
the bottom of the culture flask forming a spindle-like or fibroblas-
tic shape (Tanaka et al., 1995). These morphological changes were
induced by bombyxin at a concentration of 1 nM or higher. Five
other Bombyx cell lines, all of which were derived from embryos,
did not respond to bombyxin at concentrations up to 1μM.
A bombyxin-like peptide of M. sexta has been suggested to
be involved in the pupal commitment of wing imaginal discs
(Koyama et al., 2008). At the beginning of the final larval instar,
wing discs are committed to initiate larval-pupal development.
Juvenile hormone (JH) prevents this commitment in earlier
instars and in starved final instar larvae, but nutrient intake
overcomes this effect of JH in the latter (Truman et al., 2006).
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Thus, an insulin/IGF signal was hypothesized tomediate the effect
of nutrients. When wing discs from freshly molted final instar
larvae were cultured in vitro with methoprene, a JH mimic, the
expression level of broad, a molecular marker for pupal commit-
ment, was suppressed. The suppression effect of JH, however, was
overcome by the administration of partially purified Manduca
bombyxin or bovine insulin, supporting the above-mentioned
hypothesis.
As described in section Discovery of Bombyxin, bombyxin
did not stimulate Bombyx PGs in the debrained pupal assay or
in the conventional in vitro PG assay. Recently, however, it was
demonstrated that bovine insulin stimulates ecdysteroidogenesis
in Bombyx PGs during a long-term incubation period (Gu
et al., 2009). A significant increase in ecdysteroid secretion by
the PGs was observed after 8 h of incubation with insulin at
a concentration of 1.7μM or higher. In addition, insulin also
stimulated DNA synthesis and cell viability of PGs, as assayed
after 48 h of incubation. The PG-stimulating action of insulin was
also verified by in vivo experiments: injection of insulin into day
6 last instar larvae significantly increased both the hemolymph
ecdysteroid titers and in vitro ecdysteroidogenic activity of the
PGs 24 h after the injection. Although bovine insulin was used in
this study, the results strongly suggest that bombyxin, intrinsic
insulin of B. mori, has the same long-term actions on the PGs.
The effects of insulin-like peptides on ecdysteroidogenesis in PGs
are also demonstrated in D. melanogaster (Caldwell et al., 2005;
Colombani et al., 2005; Mirth et al., 2005; Walkiewicz and Stern,
2009).
BOMBYX IGF-LIKE PEPTIDE (BIGFLP)
DISCOVERY OF BIGFLP
As described in section Measurement of Bombyxin, the
hemolymph bombyxin titer, as measured by RIA, is remarkably
high during metamorphosis (Saegusa et al., 1992). The titers
were so high the authors suspected that the immunoreactivity
in the pupal hemolymph did not represent bombyxin, because
it was unlikely that only eight neurosecretory cells in the brain
could secrete such large amounts of bombyxin. Therefore, pupal
hemolymph was analyzed by Western blotting using M7H2 anti-
body, the same antibody as used for RIA, to estimate the molec-
ular mass of the immunoreactive material. It was 8 kDa, slightly
larger than that of bombyxin-II and similar to that of a bombyxin
precursor polypeptide. Thus, it was decided to purify this peptide
to determine its structure. The peptide was effectively enriched
from pupal hemolymph using an M7H2 antibody-bound affin-
ity column and further purified to homogeneity through only
two steps of HPLC (Okamoto et al., 2009a). The amino acid
sequence of the peptide was determined by a combination of
N-terminal sequencing, Bombyx genome search and MALDI
TOF-MS analysis. The peptide had high homology with bom-
byxins and most interestingly it contained the C-domain within
the molecule. Although the C-domain was flanked by dibasic
amino acid motifs, it was obvious that this peptide is secreted
into hemolymph as a single chain peptide like IGFs, because it
was purified from the hemolymph. For this and some other rea-
sons described below, this peptide was named BIGFLP (Okamoto
et al., 2009a).
BIGFLP-PRODUCING CELLS
Although all known bombyxins are mainly produced byMNCs in
the brain (Mizoguchi et al., 1987; Iwami, 2000), expression anal-
ysis by real-time quantitative RT-PCR (qRT-PCR) revealed that
BIGFLP is predominantly produced by the fat body (Okamoto
et al., 2009a). The fat body is the functional equivalent of the
vertebrate liver, which is the major source of circulating IGFs.
BIGFLP gene expression in the fat body was very low during
larval stages but dramatically increased during metamorphosis.
Production of BIGFLP by the fat body was also confirmed by
immunohistochemistry with a BIGFLP-specific monoclonal anti-
body (D7H3) generated against its C-domain (Okamoto et al.,
2009a, 2011). BIGFLP-producing tissues and stages were sys-
tematically surveyed by means of immunohistochemistry, in situ
hybridization, as well as qRT-PCR (Okamoto et al., 2011). These
analyses revealed that BIGFLP is produced not only by the fat
body but also by the brain and gonads in a stage-specific manner
(Okamoto et al., 2011). The BIGFLP-producing cells in the brain
were identical to the cells that produce bombyxins, but the tempo-
ral expression pattern of BIGFLP was clearly different from that of
bombyxins. BIGFLP is produced in the brain only after the penul-
timate (fourth) instar stage. In the ovary, BIGFLP expression was
observed in the ovariole sheath, which wraps around an array of
follicles, during the wandering and early pupal stages. The sheath
of testis also produces BIGFLP during pupa-adult development.
REGULATION OF BIGFLP PRODUCTION AND RELEASE
The temporal expression patterns of the BIGFLP gene in the fat
body and gonads suggested that BIGFLP production in these
organs is regulated by ecdysteroids, which are released concur-
rently. This hypothesis was verified though the experiments where
these tissues were cultured in vitro with 20E (Okamoto et al.,
2009a, 2011). In contrast, BIGFLP expression in the brain was
not induced by 20E (Okamoto et al., 2011). These results indi-
cate that the regulatory mechanisms of BIGFLP gene expression
differ across tissues.
BIGFLP titers in the hemolymph were determined by TR-FIA
using two antibodies, one of which (capture antibody) was a
BIGFLP-specific mouse monoclonal antibody (D11E12) against
its C-domain and the other (tracer antibody) was anti-bombyxin-
II guinea pig polyclonal antibody that cross-reacts with BIGFLP.
The BIGFLP titers were remarkably high, with the titer rising early
in the pupal stage to 800 nM in females and 200 nM in males.
These values are much more similar to those of IGFs in human
adults (20–80 nM) (Humbel, 1990) than to those of bombyxin
and insulin, which are of the order of 100 pM (Andersen et al.,
1993; Satake et al., 1999).
BIGFLP ACTIONS
Lepidopteran pupae initiate adult development shortly after
pupal ecdysis, when larval tissues degenerate, while adult tissues
including reproductive system, imaginal discs and flight mus-
cles undergo growth and differentiation. The temporal secretion
pattern of BIGFLP suggested that BIGFLP regulates growth and
development of adult tissues during metamorphosis. The poten-
tial growth-promoting effect of BIGFLP was investigated using
an in vitro tissue culture system. When genital imaginal discs
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were cultured with BIGFLP, the tissue size, protein content and
cell number of the discs were significantly increased after 5 days.
BIGFLP also promoted BrdU incorporation not only in genital
discs but also in sperm ducts, flight muscle anlagen and wing
discs. Interestingly, no or little promotion of BrdU incorporation
by BIGFLP was observed in the fat body, midgut and epidermis,
all of which are degenerated or reconstructed during adult devel-
opment, suggesting that BIGFLP functions as a growth hormone
to regulate adult tissue development in B. mori (Okamoto et al.,
2009a).
Although the dominant source of BIGFLP in the hemolymph
is the fat body, several other tissues including brain and gonads
also produce BIGFLP (see section BIGFLP-Producing Cells).
For example, the ovariole sheath produces BIGFLP during the
period when the ovaries undergo rapid growth and development.
BIGFLP expression is especially high in the area where folli-
cles are immature. Interestingly, the Bombyx insulin-like receptor
gene is also predominantly expressed in the early vitellogenic
ovaries (Swevers and Iatrou, 2003). Thus, ovariole sheath-derived
BIGFLP may regulate the early follicular growth in a paracrine
manner. Thus, BIGFLP may exert its effects through both
endocrine and paracrine pathways, as do the vertebrate IGFs.
IGF-LIKE PEPTIDE IN DROSOPHILA
CANDIDATES FOR IGF-LIKE PEPTIDES IN OTHER INSECTS
Are IGF-like peptides present in insects other than B. mori? Based
on sequence homology, no obvious orthologs of BIGFLP have
been identified in other insects, because the amino acid sequences
of insect insulin-related peptides are highly diverged between
insect orders, except for some critical residues necessary for ter-
tiary structure formation. One of the characteristic features of
IGFs as compared to proinsulin is a shortened C-domain. In this
regard, some insulin-related peptides in insects are more simi-
lar to IGFs than to insulin (Figure 2). Such peptides are found
in D. melanogaster (DILP6) (Brogiolo et al., 2001), A. mellifera
(AmILP1) (Wheeler et al., 2006), the red flour beetle Tribolium
castaneum (TcILP3) (Li et al., 2008), and the mosquito Aedes
aegypti (AaegILP6) (Riehle et al., 2006).
Another characteristic feature of the IGF-like peptide in B.
mori is a very high level of gene expression in the fat body during
metamorphosis. Therefore, insulin-related genes in other insects
showing such an expression pattern are good candidates for being
IGF-like peptides. Although bombyxin genes and a majority of
known insect insulin-related genes are mainly expressed inMNCs
of the brain (Mizoguchi et al., 1987; Iwami, 2000; Brogiolo et al.,
FIGURE 2 | Predicted insulin-like and IGF-like peptides in insects. Amino
acid sequences of the representatives of putative insulin-like (A) and IGF-like
(B) peptides from B. mori (bombyxin-II and BIGFLP), D. melanogaster (DILP2
and 6), A. aegypti (AaegILP2 and 6), A. mellifera (AmILP2 and 1), T.
castaneum (TcILP2 and 3), and Schistocerca gregaria (ScgIRP) are aligned.
Highly conserved amino acid residues are shown in red. Color bars below the
alignment indicate the predicted domains in the precursor peptides: green,
signal peptide; red, B-domain; yellow, C-domain; blue, A-domain. Asterisks
denote cysteine residues, and paired triangles denote potential cleavage
sites (dibasic amino acids).
www.frontiersin.org August 2013 | Volume 4 | Article 217 | 7
Mizoguchi and Okamoto Insulin-like and IGF-like peptides in Bombyx mori
2001; Ikeya et al., 2002; Rulifson et al., 2002; Broughton et al.,
2005; Nässel, 2012), some insulin-related genes are expressed
outside the brain (Brogiolo et al., 2001; Riehle et al., 2006).
DILP6 AS A DROSOPHILA IGF-LIKE PEPTIDE
In D. melanogaster, developmental changes in the gene expression
of seven DILPs were investigated from embryo to adult (Okamoto
et al., 2009b; Slaidina et al., 2009). These analyses revealed that
only dilp6 was expressed predominantly during the late third
instar and during pupa-adult development, at remarkably high
levels. Furthermore, dilp6 exhibited the highest expression in
the fat body. These characteristics of dilp6 expression, together
with the structural feature of DILP6, led to its identification as
a Drosophila IGF-like peptide. Interestingly, dilp6 expression in
the fat body is induced in vitro by 20E (Okamoto et al., 2009b;
Slaidina et al., 2009), as is BIGFLP (Okamoto et al., 2009a). The
ecdysteroid-induced expression of dilp6 in the fat body is not
affected by cycloheximide, a protein synthesis inhibitor, suggest-
ing that dilp6 expression is directly induced by 20E (Okamoto
et al., 2009b). The expression of dilp6 in the fat body is also
up-regulated by starvation of larvae through direct induction by
Forkhead box O (FOXO) transcription factor, independent of the
ecdysteroids (Slaidina et al., 2009), suggesting that DILP6 also
plays some roles during starved conditions. A recent study has
shown that dilp6 expression in the adult fat body is also regulated
by FOXO (Bai et al., 2012). This FOXO-inducible dilp6 expres-
sion is suggested to be involved in the compensatory regulation
between fat body-derived and brain-derived DILPs (Grönke et al.,
2010; Bai et al., 2012).
DILP6 FUNCTIONS
Several research groups independently generated dilp6 mutants
and revealed that these mutants result in ∼10% reduced final
adult body size and weight (Okamoto et al., 2009b; Slaidina et al.,
2009; Zhang et al., 2009; Grönke et al., 2010). The hair density
analysis demonstrated that dilp6 mutants have normal cell size
but reduced cell number, which likely accounts for the reduction
in body size (Okamoto et al., 2009b). Based on the temporal dilp6
expression pattern, DILP6 was expected to regulate growth dur-
ing metamorphosis. The developmental changes in body weight
were investigated in the dilp6 mutants from the beginning of the
3rd instar to adult emergence (Okamoto et al., 2009b). During the
feeding period in the 3rd instar, the growth rate was the same as
controls. However, the difference in body weight between controls
and dilp6 mutants wasmanifested during the post-feeding period.
The dilp6 mutants lost weight at a higher rate and emerged as
smaller adult flies. During the wandering and adult developmen-
tal stages, when animals never feed, the nutrient supply is limited
to the stored nutrients that have been accumulated during the
feeding period. Therefore, this dilp6 mutant phenotype suggests
a role for DILP6 in regulating the utilization efficiency of nutrient
stores during the post-feeding stages. This phenotype is rescued
by fat body-specific expression of dilp6 during the post-feeding
period (Okamoto et al., 2009b). Furthermore, when dilp6 was
overexpressed during the post-feeding period, the body weight of
adult flies was increased compared with control animals, showing
that the effect of DILP6 on adult size is closely related to its
expression level (Okamoto et al., 2009b). Similar results were also
obtained by using Gal4/Gal80ts temporal conditional expression
system to induce dilp6 RNAi or overexpression during the post-
feeding period (Slaidina et al., 2009). These studies demonstrate
that DILP6 is involved in the regulation of postfeeding growth
(Okamoto et al., 2009b; Slaidina et al., 2009).
Recent several studies have demonstrated that DILP6 act
locally within the central nervous system (Chell and Brand, 2010;
Sousa-Nunes et al., 2011; Avet-Rochex et al., 2012). A subset of
glia expresses dilp6 during the feeding stages of larvae, and its
expression is inhibited by starvation. This nutrient-dependent
expression and/or secretion of DILP6 activate the insulin/IGF sig-
naling in the adjacent neuroblasts, thereby leading to their exit
from quiescence (Chell and Brand, 2010; Sousa-Nunes et al.,
2011). Moreover, DILP6 has also been suggested to regulate the
proliferation of perineural and cortex glia in the larval brain
(Avet-Rochex et al., 2012). Thus, the fat body-derived DILP6
promotes systemic growth in an endocrine fashion, while the glia-
derived DILP6 regulates neuroblast reactivation and gliogenesis
in a paracrine/autocrine manner.
CONCLUDING REMARKS
Two classes of insulin-related peptides were discovered and char-
acterized in B. mori; one is bombyxin, which is a functional
counterpart of vertebrate insulin, and the other is BIGFLP, which
is more similar to IGFs rather than to insulin in the struc-
tural and biological traits. However, these two peptides are not
FIGURE 3 | Comparison of bombyxin and BIGFLP of B. mori with
insulin and IGF-I of humans. High similarities are noted between
bombyxin (A) and insulin (C) and between BIGFLP (B) and IGF-I (D) in the
structural feature, sites of production, secretion control, and actions.
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complete homologues of insulin and IGF, because they are pre-
sumed to share the same receptor (Okamoto et al., 2009b) and
therefore have essentially the same actions, unlike insulin and
IGF, each of which has its own receptor. Nevertheless, it is still
conceivable that bombyxin and BIGFLP are functional counter-
parts of insulin and IGF, respectively, for the following reasons.
(1) The essential role of insulin and bombyxin, both of which
are secreted after food intake, is to convey information about the
nutritional conditions of the body to the peripheral tissues. (2)
IGF and BIGFLP are secreted to promote tissue growth under the
control of specific hormones that are released at specific stages
of development. (3) IGF and BIGFLP are mainly produced by
homologous tissues, the liver and the fat body, respectively, and
are also produced by other peripheral tissues. Thus, although the
actions on target tissues may be the same, the physiological func-
tions of the two hormones are distinct. It is likely that bombyxin
serves as a link between food intake and larval growth, while
BIGFLP plays a role in facilitatingmetamorphic growth under the
control of the developmental signal, ecdysteroid. Both hormones
may also regulate energy metabolism to support the growth of
the animal. Figure 3 compares the corresponding insulin-family
peptides between B. mori and humans.
Despite striking functional similarities between insulin and
bombyxin and between IGF and BIGFLP, it is unlikely that the
ancestral insulin and IGF had already existed even prior to the
divergence of protostomes and deuterostomes, because BIGFLP
is much more similar to bombyxin than IGFs in its amino
acid sequence. Both classes of insulin-family peptides may have
evolved independently in vertebrates and insects (even in differ-
ent groups of insects) from a single ancestral insulin/IGF peptide,
as discussed by Okamoto et al. (2009b). In insects, this ances-
tral peptide may have been produced by various tissues including
the brain and fat body but differentially regulated at the level of
gene expression and/or of secretion in a tissue specific manner.
We surmise that in the course of evolution of each insect group,
gene duplications followed by divergence may have led to the
brain-specific expression of an insulin-like gene(s) and to the fat
body-specific expression of an IGF-like gene(s).
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